265 related articles for article (PubMed ID: 12570706)
1. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure.
Di Campli C; Zileri Dal Verme L; Andrisani MC; Armuzzi A; Candelli M; Gaspari R; Gasbarrini A
Curr Med Chem; 2003 Feb; 10(4):341-8. PubMed ID: 12570706
[TBL] [Abstract][Full Text] [Related]
2. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.
Stange J; Hassanein TI; Mehta R; Mitzner SR; Bartlett RH
Artif Organs; 2002 Feb; 26(2):103-10. PubMed ID: 11879237
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.
Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F
Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
[TBL] [Abstract][Full Text] [Related]
5. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters].
Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238
[TBL] [Abstract][Full Text] [Related]
6. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
Wittebole X; Hantson P
Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
[TBL] [Abstract][Full Text] [Related]
7. [Liver support systems today].
Rikker C
Orv Hetil; 2009 Dec; 150(51):2299-307. PubMed ID: 19995693
[TBL] [Abstract][Full Text] [Related]
8. Molecular adsorbent recirculating system (MARS).
Tan HK
Ann Acad Med Singap; 2004 May; 33(3):329-35. PubMed ID: 15175774
[TBL] [Abstract][Full Text] [Related]
9. Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.
Kobashi-Margáin RA; Gavilanes-Espinar JG; Gutiérrez-Grobe Y; Gutiérrez-Jiménez AA; Chávez-Tapia N; Ponciano-Rodríguez G; Uribe M; Méndez Sánchez N
Ann Hepatol; 2011 Jun; 10 Suppl 2():S70-6. PubMed ID: 22228886
[TBL] [Abstract][Full Text] [Related]
10. Bioartificial liver: current status.
Pless G; Sauer IM
Transplant Proc; 2005 Nov; 37(9):3893-5. PubMed ID: 16386576
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
Mitzner SR
Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
[TBL] [Abstract][Full Text] [Related]
12. Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure.
Campli CD; Gaspari R; Mignani V; Stifano G; Santoliquido A; Verme LZ; Proietti R; Pola P; Silveri NG; Gasbarrini G; Gasbarrini A
Artif Organs; 2003 Jun; 27(6):565-9. PubMed ID: 12780511
[TBL] [Abstract][Full Text] [Related]
13. MARS in the treatment of liver failure: controversies and evidence.
Chiu A; Fan ST
Int J Artif Organs; 2006 Jul; 29(7):660-7. PubMed ID: 16874670
[TBL] [Abstract][Full Text] [Related]
14. Review article: the molecular adsorbents recirculating system (MARS) in liver failure.
Sen S; Mookerjee RP; Davies NA; Williams R; Jalan R
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():32-8. PubMed ID: 12423451
[TBL] [Abstract][Full Text] [Related]
15. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
[TBL] [Abstract][Full Text] [Related]
16. Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis.
Dominik A; Stange J; Baumann AK; Pfensig C; Suraj M; Ibrahim B; Eggert M
Ther Apher Dial; 2018 Apr; 22(2):196-204. PubMed ID: 29266788
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
Ash SR
Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
[TBL] [Abstract][Full Text] [Related]
18. Molecular adsorbent recirculating system: albumin dialysis-based extracorporeal liver assist device.
Kapoor D
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S280-6. PubMed ID: 12472950
[TBL] [Abstract][Full Text] [Related]
19. Clearing of toxic substances: are there differences between the available liver support devices?
Krisper P; Stadlbauer V; Stauber RE
Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
[TBL] [Abstract][Full Text] [Related]
20. Liver support systems.
Santoro A; Mancini E; Ferramosca E; Faenza S
Contrib Nephrol; 2007; 156():396-404. PubMed ID: 17464150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
